Potential for the Repurposing of Adamantane Antivirals for COVID-19 Roger F. Butterworth Review Article Open access 21 June 2021 Pages: 267 - 272
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor Sajjan RajpootTomokazu OhishiMirza S. Baig Original Research Article Open access 29 July 2021 Pages: 273 - 283
Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study Peter HansonAlan KivitzScott D. Kelley Original Research Article Open access 04 August 2021 Pages: 285 - 293
Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects Charlotte BakkerJasper van der AartGeert Jan Groeneveld Original Research Article Open access 23 June 2021 Pages: 295 - 304
Predicting Inter-individual Variability During Lipid Resuscitation of Bupivacaine Cardiotoxicity in Rats: A Virtual Population Modeling Study Matthew McDanielKevin B. FloresBelinda S. Akpa Original Research Article Open access 19 July 2021 Pages: 305 - 320
Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model Masaharu HiranoTatsuaki OkamuraTsutomu Shiroya Original Research Article Open access 14 June 2021 Pages: 321 - 329
A Novel In Vitro Model for Determining the Optimum pH and Dose Volume of New Liquid Alginate for Infant Reflux Suppression Jeanine FisherFiona McLaughlinPeter W. Dettmar Original Research Article Open access 20 July 2021 Pages: 331 - 339
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies? Reinhart SpeeckaertJo LambertNanja van Geel Current Opinion Open access 09 June 2021 Pages: 341 - 350
Long-Term Maintenance of Golimumab Effectiveness for Injection Spacing in Rheumatoid Arthritis Patients with Low Disease Activity Who Previously Received Other TNF Inhibitors: Minimum 2-year Data From an Observational Study Hiroki WakabayashiNobuto NagaoAkihiro Sudo Short Communication Open access 25 June 2021 Pages: 351 - 357